Sexually Transmitted Infection Testing Integrated With HIV Prevention and Contraceptive Services in Hair Salons in Urban South Africa.

IF 2.2 3区医学 Q3 IMMUNOLOGY JAIDS Journal of Acquired Immune Deficiency Syndromes Pub Date : 2025-08-01 DOI:10.1097/QAI.0000000000003677

Jana Jarolimova, Joyce Yan, Sabina Govere, Sthabile Shezi, Lungile M Ngcobo, Shruti Sagar, Dani Zionts, Nduduzo Dube, Robert A Parker, Ingrid V Bassett

{"title":"Sexually Transmitted Infection Testing Integrated With HIV Prevention and Contraceptive Services in Hair Salons in Urban South Africa.","authors":"Jana Jarolimova, Joyce Yan, Sabina Govere, Sthabile Shezi, Lungile M Ngcobo, Shruti Sagar, Dani Zionts, Nduduzo Dube, Robert A Parker, Ingrid V Bassett","doi":"10.1097/QAI.0000000000003677","DOIUrl":null,"url":null,"abstract":"Introduction: Curable sexually transmitted infections (STIs) cause morbidity for women and increase HIV transmission and acquisition. To address barriers to STI care, we are implementing STI testing integrated with HIV prevention and contraceptive services in hair salons in urban South Africa.Methods: Women attending hair salons are offered oral HIV pre-exposure prophylaxis (PrEP), hormonal contraception, and testing for gonorrhea, chlamydia, trichomoniasis, and syphilis within an ongoing pilot trial. Participants with positive STI results are offered treatment at the salon or local clinic. Demographics, symptoms, and risk factors are collected using structured questionnaires.Results: Of 125 women enrolled and taking PrEP and/or contraceptives in the hair salons (median age 26 years, 28.8% living with HIV), 121 (96.8%) accepted STI testing and 117 (93.6%) had complete results. Nearly half (47.8%) reported a primary sex partner ≥5 years older, 32.2% thought their partner had other partners, and 62.6% reported never using condoms. In total, 42 of 117 women (35.9%) had at least 1 STI: 7.7% gonorrhea, 21.4% chlamydia, 4.3% trichomoniasis, and 9.4% syphilis. Only 8 of 42 (19.0%) women with an STI reported symptoms. In adjusted models, having an STI was associated with perceived male partner concurrency ( P = 0.049). Among women with any STI, 38 of 42 (90.5%) elected treatment at the salon.Conclusions: STI testing in hair salons in South Africa reaches women with risk factors for STIs and HIV, seems acceptable and feasible, and reveals a high STI prevalence. Hair salons may serve as novel venues to increase the reach of STI testing to women at risk for HIV and STIs.Clinical trials registration: NCT04222504.","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":"359-367"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187152/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003677","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Curable sexually transmitted infections (STIs) cause morbidity for women and increase HIV transmission and acquisition. To address barriers to STI care, we are implementing STI testing integrated with HIV prevention and contraceptive services in hair salons in urban South Africa.

Methods: Women attending hair salons are offered oral HIV pre-exposure prophylaxis (PrEP), hormonal contraception, and testing for gonorrhea, chlamydia, trichomoniasis, and syphilis within an ongoing pilot trial. Participants with positive STI results are offered treatment at the salon or local clinic. Demographics, symptoms, and risk factors are collected using structured questionnaires.

Results: Of 125 women enrolled and taking PrEP and/or contraceptives in the hair salons (median age 26 years, 28.8% living with HIV), 121 (96.8%) accepted STI testing and 117 (93.6%) had complete results. Nearly half (47.8%) reported a primary sex partner ≥5 years older, 32.2% thought their partner had other partners, and 62.6% reported never using condoms. In total, 42 of 117 women (35.9%) had at least 1 STI: 7.7% gonorrhea, 21.4% chlamydia, 4.3% trichomoniasis, and 9.4% syphilis. Only 8 of 42 (19.0%) women with an STI reported symptoms. In adjusted models, having an STI was associated with perceived male partner concurrency ( P = 0.049). Among women with any STI, 38 of 42 (90.5%) elected treatment at the salon.

Conclusions: STI testing in hair salons in South Africa reaches women with risk factors for STIs and HIV, seems acceptable and feasible, and reveals a high STI prevalence. Hair salons may serve as novel venues to increase the reach of STI testing to women at risk for HIV and STIs.

Clinical trials registration: NCT04222504.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在南非城市的美发沙龙中，性传播感染检测与艾滋病毒预防和避孕服务相结合。

导言：可治愈的性传播感染（STIs）导致妇女发病，并增加艾滋病毒的传播和获取。为了解决性传播感染护理方面的障碍，我们正在南非城市的美发沙龙实施性传播感染检测，并将其与艾滋病毒预防和避孕服务结合起来。方法：在一项正在进行的试点试验中，向参加美发沙龙的妇女提供口服艾滋病毒暴露前预防（PrEP）、激素避孕和淋病、衣原体、滴虫病和梅毒检测。性传播感染结果呈阳性的参与者可在沙龙或当地诊所接受治疗。使用结构化问卷收集人口统计、症状和风险因素。结果：125名妇女（中位年龄26岁，28.8%感染艾滋病毒）入组并在发廊使用PrEP和/或避孕药具，121名（96.8%）接受了性传播感染检测，117名（93.6%）有完全结果。近一半（47.8%）的人报告其主要性伴侣年龄大于5岁，32.2%的人认为其性伴侣有其他性伴侣，62.6%的人报告从未使用安全套。42/117名妇女（35.9%）至少有一种性传播感染：淋病7.7%，衣原体21.4%，滴虫4.3%，梅毒9.4%。只有8/42（19.0%）的性传播感染妇女报告了症状。在调整后的模型中，性传播感染与男性伴侣并发性相关（p=0.049）。在患有任何性传播感染的妇女中，38/42（90.5%）选择在沙龙接受治疗。结论：南非发廊的性传播感染检测覆盖了具有性传播感染和艾滋病毒危险因素的妇女，这似乎是可以接受和可行的，并揭示了较高的性传播感染患病率。美发沙龙可以作为一种新的场所，增加对艾滋病毒和性传播感染风险妇女进行性传播感染检测的范围。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

JAIDS Journal of Acquired Immune Deficiency Syndromes 医学-传染病学

CiteScore

5.80

自引率

5.60%

发文量

490

审稿时长

3-6 weeks

期刊介绍： JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.